ALDH1A1 and colorectal neoplasm: Furthermore, unlike for 4-HC in vitro, DEAB was unable to alter colorectal tumor cell sensitivity to Irinotecan, suggesting that the target of this inhibitor (ALDH1 enzyme activity) plays an important role in resistance to CPA, and resistance to Irinotecan appears to involve another mechanism.